Deciphering a hydrogen sulfide-related signature to supervise prognosis and therapeutic response in colon adenocarcinoma

被引:0
|
作者
Chen, Jinbiao [1 ]
Zhang, Yingchun [1 ]
机构
[1] Zhejiang Univ, Hangzhou Xixi Hosp, Med Coll, Dept Oncol, Hangzhou 310023, Zhejiang, Peoples R China
关键词
colon adenocarcinoma; hydrogen sulfide; immunotherapy; nomogram; prognosis; CLASS DISCOVERY; CANCER; RESISTANCE;
D O I
10.1097/MD.0000000000040031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hydrogen sulfide (H2S) is a critical molecule that participates in various molecular, physiological, and pathophysiological processes in biological systems. Emerging evidence has revealed that H2S is implicated in the progression of colon cancer and immune escape. Against this backdrop, the present study aimed to construct a prognostic risk feature for colon adenocarcinoma (COAD) by leveraging hydrogen sulfide-related genes (HSRG). Transcriptomic data and corresponding clinical-pathological information of colon cancer were obtained from The Cancer Genome Atlas and gene expression omnibus databases. Univariate Cox regression analysis was employed to assess the prognostic relevance of HSRG. Consensus clustering was utilized to perform molecular subtyping of COAD, followed by comparison of immune cell infiltration, drug sensitivity, and immune therapy response between subtypes. Differential expression gene and gene set enrichment analyses were conducted between subtypes. Univariate, lasso, and multivariate Cox regression analyses were applied to construct a prognostic model derived from HSRG. A nomogram model for predicting COAD prognosis was constructed and evaluated. In this study, we identified 12 HSRGs that were associated with COAD prognosis. Consensus clustering analysis revealed 3 COAD molecular subtypes that exhibited significant differences in terms of prognosis, tumor immune cell infiltration, drug sensitivity, and immune therapy response. Gene set enrichment analysis demonstrated that immunoregulatory processes were significantly suppressed in the poor-prognosis subtype while Wnt-related pathways and processes were significantly upregulated. Based on the differentially expressed genes between subtypes, we constructed a risk model comprising 11 genes that effectively distinguished high-risk patients from low-risk patients with significant associations with patient survival outcomes, drug treatment, pathological staging, and T staging. The HSRG-derived risk feature was an independent prognostic factor for COAD in drug treatment and pathological staging and could be integrated into a nomogram for prognosis prediction. Calibration curve, receiver operating characteristic curve, and decision curve analysis demonstrated excellent performance of the nomogram in evaluating COAD prognosis. Our study systematically assessed the prognostic significance of HSRG in COAD, identified HSRG-based molecular subtypes and risk features, and highlighted their potential utility in predicting prognosis and treatment response.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
    Liu, Cong
    Liu, Dingwei
    Wang, Fangfei
    Xie, Jun
    Liu, Yang
    Wang, Huan
    Rong, Jianfang
    Xie, Jinliang
    Wang, Jinyun
    Zeng, Rong
    Zhou, Feng
    Xie, Yong
    FRONTIERS IN MEDICINE, 2022, 9
  • [22] An intratumor heterogeneity-related signature for predicting prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
    Liu, Cong
    Liu, Dingwei
    Xie, Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 52 - 52
  • [23] An intratumor heterogeneity-related signature for predicting prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
    Liu, Cong
    Liu, Dingwei
    Xie, Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 52 - 52
  • [24] Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
    Chen, Pan
    Yu, Jun
    Luo, Qian
    Li, Jie
    Wang, Wei
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [25] A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma
    Cheng, Xuehua
    Wei, Yong
    Fu, Yugang
    Li, Jiacheng
    Han, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients
    Chang, Kaili
    Yuan, Chong
    Liu, Xueguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
    Ye, Zhe
    Huang, Yiwei
    Chen, Tingting
    Wu, Youyi
    JOURNAL OF CARDIOTHORACIC SURGERY, 2025, 20 (01)
  • [28] Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
    Cao, Kui
    Liu, Mingdong
    Ma, Keru
    Jiang, Xiangyu
    Ma, Jianqun
    Zhu, Jinhong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1295 - 1311
  • [29] Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
    Yang, Jian
    Chen, Zhike
    Gong, Zetian
    Li, Qifan
    Ding, Hao
    Cui, Yuan
    Tang, Lijuan
    Li, Shiqin
    Wan, Li
    Li, Yu
    Ju, Sheng
    Ding, Cheng
    Zhao, Jun
    FRONTIERS IN GENETICS, 2022, 13
  • [30] Comprehensive analysis identifies a lactylation-related signature for predicting prognosis and guiding therapies in colon adenocarcinoma
    Chang, Huan
    Zheng, Ning
    Zhu, Xiaocheng
    GENE, 2025, 939